Re: Zenith News

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Nextblockbuster

Rank: President [?]

Points: 2717 [?]

Votes: 15 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith News

in response to

Zenith News

10BagR

posted on May 04, 2020 05:46PM

I am wondering why Zenith Epigenetics is now paying for touting its Epigenetics technology via Zacks to the US and CA Investment community unless there is an IPO planning ?? What would be the point... IMO I would first like to see a BP partnership before a IPO would be an easier sell to the US investment community

3 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply